Refractory exogenous obesity

Drug	Drug Name	Drug Description
DB01577	Metamfetamine	A sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and exogenous obesity.

Drug	Drug Name	Target	Type
DB01577	Metamfetamine	Cytochrome P450 2D6	enzyme
DB01577	Metamfetamine	Solute carrier family 22 member 3	transporter
DB01577	Metamfetamine	Solute carrier family 22 member 5	transporter
DB01577	Metamfetamine	Sodium-dependent dopamine transporter	target
DB01577	Metamfetamine	Synaptic vesicular amine transporter	target
DB01577	Metamfetamine	Trace amine-associated receptor 1	target
DB01577	Metamfetamine	Sodium-dependent serotonin transporter	target
DB01577	Metamfetamine	Sodium-dependent noradrenaline transporter	target
DB01577	Metamfetamine	Chromaffin granule amine transporter	target
DB01577	Metamfetamine	Amine oxidase [flavin-containing] A	target
DB01577	Metamfetamine	Amine oxidase [flavin-containing] B	target
DB01577	Metamfetamine	Alpha-2A adrenergic receptor	target
DB01577	Metamfetamine	Alpha-2B adrenergic receptor	target
DB01577	Metamfetamine	Alpha-2C adrenergic receptor	target

Drug	Drug Name	Phase	Status	Count